Kiryat Ata, Israel

Sharon Penias-Navon

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novetide Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharon Penias-Navon. Retrieved from https://idiyas.com/inventor/sharon-penias-navon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sharon Penias-Navon

Introduction

Sharon Penias-Navon is a notable inventor based in Kyriat Ata, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid state forms of linaclotide. Her work has implications for medical uses and the preparation of various compositions.

Latest Patents

Sharon holds a patent for "Solid state forms of Linaclotide." This patent encompasses processes for the preparation of these forms, as well as their compositions and medical applications. The solid state forms of linaclotide are particularly useful in the preparation of other solid state forms, especially the amorphous variant.

Career Highlights

Throughout her career, Sharon has demonstrated a commitment to innovation in the pharmaceutical industry. Her work at Novetide Ltd. has positioned her as a key player in the development of new medical formulations.

Collaborations

Sharon has collaborated with esteemed colleagues such as Chaim Eidelman and Hagi Alon. Their combined expertise has contributed to the advancement of their projects and the successful development of new pharmaceutical solutions.

Conclusion

Sharon Penias-Navon is a pioneering inventor whose work in solid state forms of linaclotide showcases her dedication to advancing medical science. Her contributions continue to impact the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…